FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ida Minchella

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Gaetano Aurilio; Edoardo Botteri; Marco Colleoni; Daniela Cullurà; Giuseppe Curigliano; Angela Esposito; Aron Goldhirsch; Ida Minchella; Elisabetta Munzone; Laura Adamoli; Angela Sciandivasci; Franco Nolè
Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort report.
Chiara Catania; Tommaso De Pas; Ida Minchella; Filippo de Braud; Daniela Micheli; Laura Adamoli; Gianluca Spitaleri; Cristina Noberasco; Alessandra Milani; Maria Giulia Zampino; Francesca Toffalorio; Davide Radice; Aron Goldhirsch; Franco Nolè
"Waiting and the waiting room: how do you experience them?" emotional implications and suggestions from patients with cancer.
Elisabetta Munzone; F Nolé; Aron Goldhirsch; Edoardo Botteri; Angela Esposito; Laura Zorzino; Giuseppe Curigliano; Ida Minchella; Laura Adamoli; Maria Cristina Cassatella; Chiara Casadio; Maria Teresa Sandri
Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ida Minchella (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Gaetano Aurilio; Edoardo Botteri; Marco Colleoni; Daniela Cullurà; Giuseppe Curigliano; Angela Esposito; Aron Goldhirsch; Ida Minchella; Elisabetta Munzone; Laura Adamoli; Angela Sciandivasci; Franco Nolè
Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort report.
The breast journal 2012;18(5):470-4.
2011: Chiara Catania; Tommaso De Pas; Ida Minchella; Filippo de Braud; Daniela Micheli; Laura Adamoli; Gianluca Spitaleri; Cristina Noberasco; Alessandra Milani; Maria Giulia Zampino; Francesca Toffalorio; Davide Radice; Aron Goldhirsch; Franco Nolè
"Waiting and the waiting room: how do you experience them?" emotional implications and suggestions from patients with cancer.
Journal of cancer education : the official journal of the American Association for Cancer Education 2011;26(2):388-94.
2010: Elisabetta Munzone; F Nolé; Aron Goldhirsch; Edoardo Botteri; Angela Esposito; Laura Zorzino; Giuseppe Curigliano; Ida Minchella; Laura Adamoli; Maria Cristina Cassatella; Chiara Casadio; Maria Teresa Sandri
Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer.
Clinical breast cancer 2010;10(5):392-7.
2010: Monica Iorfida; Vincenzo Bagnardi; Alessandra Balduzzi; Silvia Dellapasqua; Anna Cardillo; Alberto Luini; Mattia Intra; Ida Minchella; Paolo Veronesi; Giuseppe Viale; Aron Goldhirsch; Marco Colleoni
Preoperative therapy with trastuzumab and oral vinorelbine (+/- endocrine therapy) in patients with HER2-positive breast cancer.
Breast (Edinburgh, Scotland) 2010;19(2):128-32.
2010: Elisabetta Munzone; A Di Pietro; Aron Goldhirsch; Ida Minchella; Elena Verri; M Cossu Rocca; Cristina Marenghi; Giuseppe Curigliano; Davide Radice; Laura Adamoli; Franco Nolè
Metronomic administration of pegylated liposomal-doxorubicin in extensively pre-treated metastatic breast cancer patients: a mono-institutional case-series report.
Breast (Edinburgh, Scotland) 2010;19(1):33-7.
2009: Katia Lorizzo; Nicola Fazio; Davide Radice; Sabrina Boselli; Leonardo Ariu; Maria Giulia Zampino; Franco Nolè; Elena Magni; Raffaele Ardito; Ida Minchella; Andrea Rocca; Giovanni Di Meglio; Michela Squadroni; Filippo de Braud
Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer.
Cancer chemotherapy and pharmacology 2009;64(2):301-6.
2008: F Nolé; Elisabetta Munzone; Laura Zorzino; Ida Minchella; Michela Salvatici; Edoardo Botteri; Marta Medici; Elena Verri; Laura Adamoli; Nicole Rotmensz; Aron Goldhirsch; Maria Teresa Sandri
Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(5):891-7.
2007: Chiara Catania; Marta Medici; Elena Magni; Elisabetta Munzone; Daniela Cardinale; Laura Adamoli; Giuseppina Sanna; Ida Minchella; Davide Radice; Aron Goldhirsch; Franco Nolè
Optimizing clinical care of patients with metastatic breast cancer: a new oral vinorelbine plus trastuzumab combination.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(12):1969-75.
2007: Giuseppina Sanna; Lucia Franceschelli; Nicole Rotmensz; Edoardo Botteri; Laura Adamoli; Cristina Marenghi; Elisabetta Munzone; M Cossu Rocca; Elena Verri; Ida Minchella; Marta Medici; Chiara Catania; Elena Magni; Aron Goldhirsch; Franco Nolè
Brain metastases in patients with advanced breast cancer.
Anticancer research 2007;27(4C):2865-9.
2006: Franco Nolè; Chiara Catania; Elisabetta Munzone; Andrea Rocca; Elena Verri; Giuseppina Sanna; Gilda Ascione; Laura Adamoli; Maria Giulia Zampino; Ida Minchella; Aron Goldhirsch
Capecitabine/vinorelbine: an effective and well-tolerated regimen for women with pretreated advanced-stage breast cancer.
Clinical breast cancer 2006;6(6):518-24.
2004: Giuseppe Curigliano; Rodrigo Rigo; Marco Colleoni; Fillippo De Braud; Franco Nole; Vincenzo Formica; Laura Orlando; Saverio Cinieri; Rosalba Torrisi; Anna Cardillo; Giulia Peruzzotti; Marta Medici; Raffaelle Ardito; Ida Minchella; Aron Goldhirsch
Adjuvant therapy for very young women with breast cancer: response according to biologic and endocrine features.
Clinical breast cancer 2004;5(2):125-30.
2003: Marco Colleoni; Giuseppe Curigliano; Ida Minchella; Giulia Peruzzotti; Franco Nolè; Giovanni Mazzarol; Giuseppe Renne; Laura Orlando; Andrea Rocca; Paolo Veronesi; Mattia Intra; Giuseppe Viale; M T Sandri; Gianluca Severi; Aron Goldhirsch
Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction: cytotoxic treatment during the surgical phase.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(10):1477-83.
2002: Giuseppe Curigliano; mario mandala; Ida Minchella; Aron Goldhirsch
Mediastinal lymphoadenopathy in a patient with breast cancer.
The lancet oncology 2002;3(3):174.
2001: Laura Orlando; Marco Colleoni; Giuseppe Curigliano; Franco Nolè; G Ferretti; Giovanna Masci; Giulia Peruzzotti; Ida Minchella; Mattia Intra; Paolo Veronesi; Giuseppe Viale; Aron Goldhirsch
Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimen.
Anticancer research 2001;21(6A):4135-9.
2001: Franco Nolè; Elisabetta Munzone; Mario Mandalà; Chiara Catania; Laura Orlando; Maria Giulia Zampino; Ida Minchella; Marco Colleoni; Giulia Peruzzotti; Emanuela Marrocco; Aron Goldhirsch
Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(1):95-100.
2000: Marco Colleoni; Ida Minchella; Giovanni Mazzarol; Franco Nolè; Giulia Peruzzotti; Andrea Rocca; Giuseppe Viale; Laura Orlando; G Ferretti; Giuseppe Curigliano; Paolo Veronesi; Mattia Intra; Aron Goldhirsch
Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(8):1057-9.
1999: Franco Nolè; Ida Minchella; Marco Colleoni; Enrico Orvieto; Elisabetta Munzone; Filippo de Braud; Giulia Peruzzotti; Giovanni Martinelli; Maria Giulia Zampino; Chiara Catania; Maria Pizzamiglio; Paolo Veronesi; Stefano Zurrida; Viviana Galimberti; Aron Goldhirsch; Umberto Veronesi
Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(8):993-6.
1999: Marco Colleoni; Enrico Orvieto; F Nolé; Laura Orlando; Ida Minchella; Giuseppe Viale; Giulia Peruzzotti; Chris Robertson; Cristina Noberasco; Viviana Galimberti; Virgilio Sacchini; Paolo Veronesi; Stefano Zurrida; Roberto Orecchia; Aron Goldhirsch
Prediction of response to primary chemotherapy for operable breast cancer.
European journal of cancer (Oxford, England : 1990) 1999;35(4):574-9.
1998: Marco Colleoni; Franco Nole; Ida Minchella; Cristina Noberasco; Alberto Luini; Roberto Orecchia; Paolo Veronesi; Stefano Zurrida; Giuseppe Viale; Aron Goldhirsch; A Orecchia
Pre-operative chemotherapy and radiotherapy in breast cancer.
European journal of cancer (Oxford, England : 1990) 1998;34(5):641-5.
1997: Franco Nolè; Filippo de Braud; M Aapro; Ida Minchella; M De Pas; Maria Giulia Zampino; S Monti; Gisella Andreoni; Aron Goldhirsch
Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(9):865-70.